Cargando…
The effect of azithromycin on sputum inflammatory markers in bronchiectasis
BACKGROUND: Long term macrolide treatment has been found beneficial in bronchiectasis (BE) -pathogical bronchial dilatation- possibly due to a combined anti-bacterial and immunomodulatory effect. The exact mechanism of inflammatory response is unknown. Here, we investigated the effect of maintenance...
Autores principales: | Terpstra, L. C., Altenburg, J., Doodeman, H. J., Piñeros, Y. S. Sabogal, Lutter, R., Heijerman, H. G. M., Boersma, W. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148509/ https://www.ncbi.nlm.nih.gov/pubmed/37118704 http://dx.doi.org/10.1186/s12890-023-02444-1 |
Ejemplares similares
-
The BATTLE study: Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis. Study protocol of a double blind, randomized, placebo-controlled trial: study protocol
por: Terpstra, L.C., et al.
Publicado: (2022) -
Effects of long-term tobramycin inhalation solution (TIS) once daily on exacerbation rate in patients with non-cystic fibrosis bronchiectasis
por: Terpstra, Lotte C., et al.
Publicado: (2022) -
Treatment with inhaled antibiotics in bronchiectasis, side effects, and evaluation of the tolerance test; analysis from the BATTLE randomized controlled trial
por: Terpstra, Lotte C., et al.
Publicado: (2023) -
Azithromycin and the microbiota of cystic fibrosis sputum
por: Acosta, Nicole, et al.
Publicado: (2021) -
Analysis of the Sputum and Inflammatory Alterations of the Airways in Patients with Common Variable Immunodeficiency and Bronchiectasis
por: Pereira, Andrea Cristina, et al.
Publicado: (2009)